TITAN PHARMACEUTICALS INC — Director's Dealing 2014

Oct 14, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TITAN PHARMACEUTICALS INC (TTNP.OB)
CIK: 0000910267
Period of Report: 2014-10-09

Reporting Person: BHONSLE SUNIL (Director, President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-10-09	Common Stock	P	100000	$0.478	Acquired	0	Direct
2014-10-10	Common Stock	P	24000	$0.487	Acquired	0	Direct
2014-10-13	Common Stock	P	92000	$0.47	Acquired	356500	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	300757	Indirect

Footnotes

F1: Represents the weighted average purchase price for the reported transactions. The range of prices for such transactions was $0.468 to $0.49. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

F2: Represents the weighted average purchase price for the reported transactions. The range of prices for such transactions was $0.463 to $0.485. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

F3: Does not include 10,000 shares held by his adult son.

F4: The reporting person is the trustee of the family trust owning the indicated shares.